通过PAK4抑制剂抑制NAMPT
1Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.
International journal of molecular sciences
|September 28, 2024
概括
包括KPT-9274在内的PAK4抑制剂不仅向PAK4,还向NAMPT,影响癌细胞生长. 这种双重抑制表明这些癌症治疗药物的复杂作用机制.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 氨酸/氨酸激酶PAK4与癌症进展有关,其过度表达与预后不佳有关.
- 已知PAK4抑制剂KPT-9274在三阴性乳腺癌和其他癌症类型中表现出抗癌作用.
- 此外,KPT-9274还抑制了NAMPT (尼古丁胺酸转移酶),这是一个对NAD合成和细胞能量至关重要的酶.
研究的目的:
- 调查KPT-9274的增长抑制作用是由于PAK4抑制,NAMPT抑制,还是两者兼而有之.
- 为了确定其他PAK4抑制剂是否也表现出NAMPT抑制活性.
- 阐明PAK4抑制剂对PAK4和NAMPT的双重抑制的分子机制.
主要方法:
- 测试多种PAK4抑制剂对细胞生长和NAMPT活性的影响.
- 使用无细胞测试和乳腺癌细胞系来评估NAMPT抑制.
- 采用分子对接研究来确定PAK4抑制剂,PAK4和NAMPT之间的相互作用部位.
主要成果:
- 证实多种PAK4抑制剂也可以抑制NAMPT活性.
- 无细胞和细胞测试都表明这些化合物抑制了NAMPT.
- 分子对接揭示了PAK4抑制剂和PAK4和NAMPT上的残留物之间的特定相互作用.
结论:
- PAK4 抑制剂的作用机制比以前认可的更复杂,涉及PAK4和NAMPT的双重抑制.
- 这些发现表明,这些抑制剂的抗癌疗效可能源于这种联合的抑制作用.
- 需要进一步的研究,以充分理解这种双重抑制对癌细胞生长和治疗策略的影响.
相关概念视频
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K


